Virpax Pharmaceuticals Inc Stock News

BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain indications, announced today the closing of its public offering of $5.0 million of shares of the Company's common stock, par value $0.00001 per share, and pre-funded warrants t...

BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain indications, announced today the pricing of its public offering of $5.0 million of shares of the Company's common stock, par value 0.00001 per share, and/or pre-funded warrants...

BERWYN, Pa.--(BUSINESS WIRE)-- #pharma--Virpax Regains Compliance with Nasdaq Minimum Bid Price.

Virpax Pharmaceuticals (NASDAQ: VRPX ) stock is rocketing higher on Wednesday after the preclinical-stage pharmaceutical company announced positive results from a swine model pilot study. Virpax Pharmaceuticals has released results from its swine model study of Probudur.

Spotting penny stocks with breakout potential requires a keen understanding of several key factors that can indicate imminent growth. One crucial aspect is identifying companies with strong fundamentals.

Virpax Pharmaceuticals (NASDAQ: VRPX ) stock is heading higher on Monday after the preclinical-stage pharmaceutical company secured a new $2.5 million loan. Virpax Pharmaceuticals says that this funding comes from an institutional investor.

BERWYN, Pa.--(BUSINESS WIRE)-- #pharma--Virpax to Present at 2024 BIO International Convention.

Virpax Pharmaceuticals (NASDAQ: VRPX ) stock is down on Wednesday as the preclinical-stage pharmaceutical company's lackluster earnings report yesterday continues to weigh on its shares today. Considering the stage of the company's drug development pipeline, its lack of revenue for the quarter makes sense.